TransCode Therapeutics Inc (RNAZ)
0.8255
+0.01
(+0.67%)
USD |
NASDAQ |
May 06, 16:00
0.792
-0.03
(-4.06%)
After-Hours: 07:57
TransCode Therapeutics Shareholders Equity (Quarterly): 1.641M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.641M |
| September 30, 2023 | 4.440M |
| June 30, 2023 | 2.092M |
| March 31, 2023 | -0.2368M |
| December 31, 2022 | 3.241M |
| September 30, 2022 | 8.244M |
| June 30, 2022 | 12.43M |
| Date | Value |
|---|---|
| March 31, 2022 | 17.00M |
| December 31, 2021 | 20.40M |
| September 30, 2021 | 23.16M |
| June 30, 2021 | -5.036M |
| March 31, 2021 | -7.845M |
| December 31, 2020 | -3.408M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-7.845M
Minimum
Mar 2021
23.16M
Maximum
Sep 2021
5.855M
Average
3.241M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Citius Pharmaceuticals Inc | 84.73M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.170M |
| Total Liabilities (Quarterly) | 3.529M |